Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Observer Blind, Active Controlled, Randomized, Clinical Study Comparing Safety and Immunogenicity of BBio Bivalent Oral Polio Vaccine With a Licensed Bivalent Oral Polio Vaccine

NCT02766816 is registered in ClinicalTrials.gov with Bilthoven Biologicals as lead sponsor.

NCT NCT02766816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02766816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Observer Blind, Active Controlled, Randomized, Clinical Study Comparing Safety and Immunogenicity of BBio Bivalent Oral Polio Vaccine With a Licensed Bivalent Oral Polio Vaccine
Lead sponsor
Bilthoven Biologicals
Phase
Phase 3
Overall status
Completed
Start date
June 8, 2016
Completion date
February 14, 2018
Enrollment
1,120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune response to oral polio vaccine